These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 14971230)

  • 1. Chloroquine-induced retinal toxicity.
    Rivett K
    S Afr Med J; 2004 Jan; 94(1):41. PubMed ID: 14971230
    [No Abstract]   [Full Text] [Related]  

  • 2. Ophthalmologic considerations in using antimalarials in the United States.
    Rynes RI
    Lupus; 1996 Jun; 5 Suppl 1():S73-4. PubMed ID: 8803917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chloroquine-induced retinal toxicity.
    Whitelaw D; Jessop S
    S Afr Med J; 2005 Feb; 95(2):72. PubMed ID: 15751191
    [No Abstract]   [Full Text] [Related]  

  • 4. What is new in recommendations on ophthalmological screening in patients treated with chloroquine and hydroxychloroquine? Update and literature review.
    Wiacek MP; Bobrowska-Snarska D; Lubiński W; Brzosko M; Modrzejewska M
    Niger J Clin Pract; 2017 Aug; 20(8):919-923. PubMed ID: 28891533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chloroquine retinopathy.
    Felton JM
    Trop Doct; 1997 Jan; 27(1):2-4. PubMed ID: 9030009
    [No Abstract]   [Full Text] [Related]  

  • 6. More thoughts about antimalarials: should one prescribe chloroquine?
    Esdaile JM
    J Rheumatol; 1999 Sep; 26(9):1868. PubMed ID: 10493663
    [No Abstract]   [Full Text] [Related]  

  • 7. Antimalarials in the treatment of rheumatoid arthritis.
    Zvaifler NJ
    Mod Treat; 1971 Nov; 8(4):769-77. PubMed ID: 4258497
    [No Abstract]   [Full Text] [Related]  

  • 8. Retinopathy and antimalarial drugs--the British experience.
    Spalton DJ
    Lupus; 1996 Jun; 5 Suppl 1():S70-2. PubMed ID: 8803916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eye damage from chloroquine as an antimalarial: misuse makes safe medicines unsafe.
    Waddell KM
    Trop Doct; 1997 Jan; 27(1):10-2. PubMed ID: 9030011
    [No Abstract]   [Full Text] [Related]  

  • 10. Monitoring for retinal toxicity in patients taking hydroxychloroquine and chloroquine.
    Yusuf IH; Ledingham JM; MacPhie E; Lotery AJ; Galloway J
    Rheumatology (Oxford); 2019 Jan; 58(1):3-4. PubMed ID: 29529306
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimalarial drug-induced aquagenic-type pruritus in patients with lupus.
    Jiménez-Alonso J; Tercedor J; Jáimez L; García-Lora E
    Arthritis Rheum; 1998 Apr; 41(4):744-5. PubMed ID: 9550488
    [No Abstract]   [Full Text] [Related]  

  • 12. Dose relationships in patients with early chloroquine retinopathy.
    Easterbrook M
    J Rheumatol; 1987 Jun; 14(3):472-5. PubMed ID: 3625628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chloroquine retinopathy: avoidable by individualized daily dosing].
    Ochsendorf FR; Runne U; Goerz G; Zrenner E
    Dtsch Med Wochenschr; 1993 Dec; 118(51-52):1895-8. PubMed ID: 8287780
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antimalarial's retinopaty remains a current threat].
    Chiffoleau A; Guillet A; Zanlonghi X; Jolliet P
    Presse Med; 2009 Apr; 38(4):662-3. PubMed ID: 19135848
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of Antimalarial Therapy in Patients Who Are Hypersensitive to Hydroxychloroquine.
    Riley K; Schwager Z; Stern M; Vleugels RA; Femia A
    JAMA Dermatol; 2019 Apr; 155(4):491-493. PubMed ID: 30758479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discoid lupus erythematosus.
    Brown RK
    Arch Dermatol; 1972 May; 105(5):768-70. PubMed ID: 4537259
    [No Abstract]   [Full Text] [Related]  

  • 17. [The cornea and synthetic antimalarials].
    Jeddi A; Ben Osman N; Daghfous F; Bouguila H; Charfi O; Ayed S
    J Fr Ophtalmol; 1994; 17(1):36-8. PubMed ID: 8176172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral manifestations associated with antimalarial therapy in patients with systemic lupus erythematosus.
    Chacón-Dulcey V; López-Labady J; Villarroel-Dorrego M; Frías J; Tirado W; González N; Pérez Alfonzo R
    Lupus; 2020 Jun; 29(7):761-766. PubMed ID: 32362181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chloroquine maculopathy and prevention of malaria].
    Balo KP; Mensah A; Mihluedo H
    J Fr Ophtalmol; 1996; 19(12):770-6. PubMed ID: 9033902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current concepts in monitoring patients on antimalarials.
    Easterbrook M
    Aust N Z J Ophthalmol; 1998 May; 26(2):101-3. PubMed ID: 9630287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.